AVANIR PHARMACEUTICALS INC - CL A NEW (AVNR)

Q4 2014 13F Holders as of 31 Dec 2014

Type / Class
Equity / CL A NEW
Total 13F shares
161,109,925
Share change
-1,803,258
Total reported value
$2,728,632,204
Put/Call ratio
30%
Price per share
$16.95
Number of holders
162
Value change
+$80,603,690
Number of buys
98
Number of sells
84

Institutional Holders of AVANIR PHARMACEUTICALS INC - CL A NEW (AVNR) as of Q4 2014

As of 31 Dec 2014, AVANIR PHARMACEUTICALS INC - CL A NEW (AVNR) was held by 162 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 161,109,925 shares. The largest 10 holders included BAKER BROS. ADVISORS LP, PRICE T ROWE ASSOCIATES INC /MD/, VANGUARD GROUP INC, BlackRock Fund Advisors, WATER ISLAND CAPITAL LLC, BlackRock Institutional Trust Company, N.A., State Street Corp, FMR LLC, OXFORD ASSET MANAGEMENT, and AQR CAPITAL MANAGEMENT LLC. This page lists 162 institutional shareholders reporting positions in this security for the Q4 2014 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.